PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,444,859 | -35.2% | 235,319 | -33.9% | 0.00% | – |
| Q2 2023 | $2,228,221 | -25.9% | 355,946 | -43.5% | 0.00% | – |
| Q1 2023 | $3,006,335 | -69.7% | 630,259 | -44.7% | 0.00% | -100.0% |
| Q4 2022 | $9,911,579 | -36.6% | 1,139,262 | -13.3% | 0.00% | -50.0% |
| Q3 2022 | $15,635,000 | -64.4% | 1,313,903 | -57.4% | 0.00% | -66.7% |
| Q2 2022 | $43,975,000 | -51.9% | 3,085,963 | -29.7% | 0.01% | -50.0% |
| Q1 2022 | $91,381,000 | +1113.6% | 4,389,070 | +1246.5% | 0.01% | +1100.0% |
| Q4 2021 | $7,530,000 | +567.6% | 325,967 | +760.3% | 0.00% | – |
| Q3 2021 | $1,128,000 | -51.7% | 37,889 | -44.5% | 0.00% | – |
| Q2 2021 | $2,335,000 | +592.9% | 68,328 | +568.4% | 0.00% | – |
| Q1 2021 | $337,000 | -82.8% | 10,223 | -67.8% | 0.00% | – |
| Q4 2020 | $1,956,000 | +698.4% | 31,796 | +360.8% | 0.00% | – |
| Q3 2020 | $245,000 | – | 6,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |